5 results
Neuroplast has scheduled to start in 2018 with a phase I and a phase II/III clinical trial with patients with a traumatic spinal cord injury to confirm the efficacy and safety in humans. A GMP license to produce clinical grade Neuro-Cells is…
The objective of this study is to determine the value of TOD (first rib resection with partial scalenectomy and neurolysis) on functionality and quality of life. We will do this by randomizing patients into who already received physiotherapy into…
To develop a prediction equation to validly estimate the body composition of people with a SCI using bioelectrical impedance analysis (BIA)To develop a prediction equation to validly estimate the resting energy expenditure of people with a SCI from…
The objective of this study is to establish safety of intrathecally administered Neuro-Cells in patients with a chronic traumatic spinal cord injury.Neuro-Cells is an autologous stem cell preparation derived from bone marrow and processed within a…
- The main objective of this study is to develop a predictive model that can estimate the rest energy expenditure in indviduals with SCI or LLA.- To develop a model based on raw accelerometry data that can estimate the energy expenditure during ADL…